Company Filing History:
Years Active: 2021-2024
Title: Starlynn Clarke: Innovator in Antibody Development
Introduction
Starlynn Clarke is a prominent inventor based in Newark, CA (US). She has made significant contributions to the field of antibody development, holding a total of 3 patents. Her work focuses on creating innovative solutions for medical disorders through the use of heavy chain antibodies.
Latest Patents
Clarke's latest patents include groundbreaking advancements in the treatment of disorders characterized by the expression of specific proteins. One of her notable patents is for heavy chain antibodies binding to PSMA. This patent discloses anti-PSMA heavy chain antibodies, along with methods for their production, compositions, including pharmaceutical formulations, and their application in treating related disorders. Another significant patent involves anti-BCMA heavy chain-only antibodies, which are designed to address B-cell disorders characterized by the expression of BCMA. This patent also includes methods of making these antibodies and their potential therapeutic uses.
Career Highlights
Throughout her career, Starlynn Clarke has worked with notable companies such as TeneoOne, Inc. and Teneobio, Inc. Her expertise in antibody development has positioned her as a key player in the biotechnology industry. Clarke's innovative approaches have led to advancements that could significantly impact the treatment of various medical conditions.
Collaborations
Clarke has collaborated with esteemed colleagues in her field, including Wim Van Schooten and Nathan D Trinklein. These partnerships have fostered an environment of innovation and have contributed to the success of her projects.
Conclusion
Starlynn Clarke's contributions to the field of antibody development are noteworthy and demonstrate her commitment to advancing medical science. Her patents and collaborations reflect her innovative spirit and dedication to improving healthcare solutions.